From heart to bad sleep—Lessons for sleep apnoea in times of crisis
Publicado na Rev Port Pneumol. 2012;18:3-4. - vol.18 núm 01
Introdução
Obstructive sleep apnoea syndrome (OSAS) is a largely prevalent disorder characterized by repeated episodes of pharyngeal obstruction that causes oxygen desaturation and sleep fragmentation. Besides the consequences of excessive daytime sleepiness including increased risk of traffic and labour accidents, OSAS has been implicated, with great or less evidence, as an independent risk factor for different cardiovascular diseases as hypertension, stroke, heart failure, arrhythmias, coronary heart disease and myocardial infarction.1 The recognition of OSAS as a treatable putative cause of hypertension and the need for screening is present in international recommendations since 2003.2 Several studies have found an association between OSAS and coronary artery disease (CAD). In a large prospective longitudinal study in men and women who were free of CAD at baseline and followed for 8.7 years, after adjustment for multiple risk factors, OSAS was positively associated to myocardial infarction, revascularization procedure or death only in men aged <70 years old (adjusted ratio 1.10 [95% CI 1.00, 1.21] per 10-unit increase in apnoea–hypopnea index), but not in older men or in women of any age.3 Other studies showed that patients suffering from CAD with an AHI greater than 10 events/hour were more prone to die in 5-year follow-up than patients without OSAS (37.5% vs. 9.3%, respectively) after controlling for age, weight, and smoking.4, 5 On the other hand in patients with CAD that had percutaneous intervention the probability of restenosis, vessel remodelling and cardiac mortality was greater in the presence of OSAS.6, 7 Moreover patients with CAD treated with CPAP...
Bibliografia
1. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et-al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med. 2001; 163:19-25.
Pubmed
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et-al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003; 289:2560-72.
3. Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT, Punjabi NM, Quan SF, et-al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010; 122(July):352-60.
Pubmed
4. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med. 2000; 162:81-6.
Pubmed
5. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF, et-al. SDB and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163:19-25.
Pubmed
6. Steiner S, Schueller PO, Hennersdorf MG, Behrendt D, Strauer BE. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res. 2008; 9(June):50.
Pubmed
7. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007; 99:26-30.
Pubmed
8. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. SDB and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001; 164:1910-3.
Pubmed
9. Milleron O, Pilliere R, Foucher A, De Rouquefeuil F, Aegerter P, Jondeau G, et-al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004; 25:728-34.
Pubmed
10. Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol. 2007; 50(October):1310-4.
Pubmed
11. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007; 176(December):1274-80.
Pubmed
12. Areias V. Sleep apnea-hypopnea syndrome and acute coronary syndrome – an association not to forget. Rev Port Pneumol. 2012; 1:.
13. Planès C, Leroy M, Bouach Khalil N, El Mahmoud R, Digne F, de Roquefeuil F, et-al. Home diagnosis of obstructive sleep apnoea in coronary patients: validity of a simplified device automated analysis. Sleep Breath. 2010; 14(February):25-32.
Pubmed
14. Skinner MA, Choudhury MS, Homan SD, Cowan JO, Wilkins GT, Taylor DR. Accuracy of monitoring for sleep-related breathing disorders in the coronary care unit. Chest. 2005; 127(January):66-71.
Pubmed
15. Caetano P, Santos AC, Almeida J, Winck JC. Prevalence of new-onset insomnia in patients with obstructive sleep apnoea syndrome treated with nocturnal ventilatory support. Rev Port Pneumol. 2012; 1:.
16. Yang CM, Liao YS, Lin CM, Chou SL, Wang EN. Psychological and behavioral factors in patients with comorbid obstructive sleep apnea and insomnia. J Psychosom Res. 2011; 70(April):355-61.
Pubmed
17. Wickwire EM, Collop NA. Insomnia and sleep-related breathing disorders. Chest. 2010; 137(June):1449-63.
Pubmed
18. Wickwire EM, Smith MT, Birnbaum S, Collop NA. Sleep maintenance insomnia complaints predict poor CPAP adherence: a clinical case series. Sleep Med. 2010; 11(September):772-6.
Pubmed
19. Nguyên XL, Chaskalovic J, Rakotonanahary D, Fleury B. Insomnia symptoms and CPAP compliance in OSAS patients: a descriptive study using Data Mining methods. Sleep Med. 2010; 11(September):777-84.
Pubmed
20. http://www.portaldasaude.gov.pt/portal/conteudos/a+saude+em+portugal/publicacoes/estudos/cuidados+respiratorios.html
Moutinho dos Santos, J.a
aCentro de Medicina do Sono do Centro Hospitalar de Coimbra, Coimbra, Portugal